For the quarter ending 2025-09-30, OMER had $491K increase in cash & cash equivalents over the period. -$18,484K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -30,917 | -58,884 |
| Stock-based compensation expense | 1,941 | 4,518 |
| Loss on early extinguishment of 2026 notes | 0 | -2,968 |
| Amortization of discount and issuance costs on debt-Convertible Debt | 1,478 | 988 |
| Remeasurement on fair value of financial instruments | -8,822 | 8,142 |
| Depreciation and amortization | 240 | 489 |
| Remeasurement on omidria royalty obligation | -22,293 | -11,878 |
| Non-cash interest on omidria contract royalty asset | 3,682 | 7,839 |
| Remeasurement of omidria contract royalty asset | 13,402 | 2,981 |
| Amortization of discount and issuance costs on debt-Loans Payable | -1,513 | -3,214 |
| Accretion on u.s. government treasury bills, net | 0 | 0 |
| Omidria contract royalty asset | -9,153 | -15,251 |
| Prepaid expenses and other | -2,398 | -315 |
| Receivables | 632 | -1,463 |
| Accounts payable and accrued expense | 3,130 | 3,205 |
| Net cash used in operating activities | -18,473 | -57,779 |
| Proceeds from the sale and maturities of investments | 10,500 | 61,000 |
| Purchases of investments | 17,350 | 1,108 |
| Purchases of property and equipment | 11 | 54 |
| Net cash provided by investing activities | -6,861 | 59,838 |
| Proceeds from issuance of common stock, net-Securities Purchase Agreement With Polar Asset Management | 20,327 | - |
| Proceeds from issuance of common stock, net-At The Market Equity Offering Program | 15,292 | - |
| Proceeds upon exercise of stock options | 225 | 88 |
| Principal payments on omidria royalty obligation | 3,555 | 6,701 |
| Payment of debt issuance costs related to 2029 notes | 0 | 2,837 |
| Payments on finance lease obligations | 177 | 392 |
| Proceeds from issuance of common stock from the atm facility, net | - | 6,287 |
| Proceeds from sale of future royalties | 0 | 0 |
| Cash paid to repurchase 2026 convertible senior notes | 0 | 0 |
| Repurchases of common stock | 0 | 0 |
| Net cash provided by financing activities | 25,825 | -3,555 |
| Net decrease in cash and cash equivalents | 491 | -1,496 |
| Cash and cash equivalents at beginning of period | 3,400 | - |
| Cash and cash equivalents at end of period | 2,395 | - |
OMEROS CORP (OMER)
OMEROS CORP (OMER)